Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on May 1, 2003

Stroke. 2003
Published online before print May 1, 2003, doi: 10.1161/01.STR.0000071107.66925.93
A more recent version of this article appeared on June 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/6/e58    most recent
01.STR.0000071107.66925.93v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rymer, M. M.
Right arrow Articles by Summers, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rymer, M. M.
Right arrow Articles by Summers, D.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Thrombolysis

Submitted on December 5, 2002
Accepted on December 23, 2002

Expanded Modes of Tissue Plasminogen Activator Delivery in a Comprehensive Stroke Center Increases Regional Acute Stroke Interventions

Marilyn M. Rymer MD*; Duane Thurtchley RN; Deborah Summers RN, MSN; and for the Mid America Brain and Stroke Institute Stroke Team

From the UMKC School of Medicine (M.M.R.) and Mid America Brain and Stroke Institute at Saint Luke's Hospital (M.M.R., D.T., D.S.), Kansas City, Mo.

* To whom correspondence should be addressed. E-mail: mrymer{at}saint-lukes.org.

Background and Purpose--We sought to evaluate whether a comprehensive stroke center could work with regional hospitals to increase the use of tissue plasminogen activator (tPA) in acute stroke.

Methods--In 30 months, 142 patients seen at the Mid America Brain and Stroke Institute received tPA. Site of presentation, protocol selection, and outcomes were analyzed.

Results--We found that 18.2% (142 of 781) of all ischemic strokes received tPA. Of those, 70% (99 of 142) were transferred from hospitals within 100 miles of Kansas City (Mo). Mortality rate was 12.7% (18 of 142). Symptomatic hemorrhage rate was 9.2%.

Conclusions--A comprehensive stroke center can serve as a hub for a regional network and increase the number of stroke interventions with acceptable outcomes.


Key words: stroke, ischemic • stroke units • thrombolysis • tissue plasminogen activator




This article has been cited by other articles:


Home page
CirculationHome page
Part 9: Adult Stroke
Circulation, December 13, 2005; 112(24_suppl): IV-111 - IV-120.
[Full Text] [PDF]


Home page
CirculationHome page
L. H. Schwamm, A. Pancioli, J. E. Acker III, L. B. Goldstein, R. D. Zorowitz, T. J. Shephard, P. Moyer, M. Gorman, S. C. Johnston, P. W. Duncan, et al.
Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association's Task Force on the Development of Stroke Systems
Circulation, March 1, 2005; 111(8): 1078 - 1091.
[Full Text] [PDF]


Home page
NeurologyHome page
J. L. Frey, H. K. Jahnke, P. W. Goslar, S. Partovi, and M. S. Flaster
tPA by telephone: Extending the benefits of a comprehensive stroke center
Neurology, January 11, 2005; 64(1): 154 - 156.
[Abstract] [Full Text] [PDF]